Form 4: Guardant Health Director Krognes Converts RSUs

Guardant Health Director Steve Krognes converted 154 Restricted Stock Units into common stock on October 31, 2025, as part of a pre-scheduled vesting.

Summary

• Director Steve E. Krognes of Guardant Health, Inc. [GH] reported a transaction involving the conversion of derivative securities.
• On October 31, 2025, Krognes converted 154 Restricted Stock Units (RSUs) into 154 shares of Guardant Health common stock.
• This transaction was an exercise or conversion of a derivative security (RSU vesting) at a price of $0.
• Following this transaction, Krognes directly beneficially owns 18,436 shares of Guardant Health common stock.
• He also directly beneficially owns 1,235 Restricted Stock Units.
• The RSUs were originally granted on August 9, 2022, with 25% vesting on June 30, 2023, and the remaining 75% vesting in substantially equal monthly installments over three years from June 30, 2023.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled vesting of restricted stock units for a director, which is a neutral event. The increase in direct common stock ownership is a slightly positive signal of continued insider alignment, but not a significant catalyst.

Positives

• Director Steve E. Krognes increased his direct beneficial ownership of Guardant Health common stock by 154 shares, demonstrating continued alignment with shareholder interests through a routine vesting event.

Future Outlook

The filing does not contain any forward-looking statements or guidance beyond the pre-scheduled vesting of existing Restricted Stock Units.

Industry Context

This transaction is a routine insider filing (Form 4) reporting the vesting of restricted stock units for a director. It reflects an individual's compensation structure and continued equity stake in the company, rather than broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders may view the director's continued accumulation of common stock through vesting as a positive sign of alignment between management and shareholder interests.

Next Steps

• The remaining 1,235 Restricted Stock Units held by Steve E. Krognes are expected to continue vesting in substantially equal monthly installments on each monthly anniversary of June 30, 2023, over the three-year period.

Key Dates

Recommendation

This Form 4 reports a routine vesting of restricted stock units for a director, which is a pre-scheduled event and does not provide new fundamental information to alter an investment thesis. It reflects continued insider ownership, which is generally neutral to slightly positive, but not a strong catalyst for a 'buy' or 'sell' recommendation.

Keywords

Guardant Health, GH, Steve Krognes, Form 4, insider transaction, RSU, restricted stock units, director, stock ownership, vesting